Newborn screening for Tyr-I: two years' experience of the New York State program.
Mol Genet Metab
; 103(2): 191-2, 2011 Jun.
Article
em En
| MEDLINE
| ID: mdl-21441051
ABSTRACT
In 2 years, the New York newborn screening program has analyzed approximately 500,000 samples for succinylacetone (SUAC), the biomarker for Tyrosinemia, type I. There have been five screen-positive results. Two of these results were considered borderline, and a repeat specimen was requested. In three cases, an immediate referral was made to a specialty care center. Two of those three cases were confirmed for Tyr-I.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Triagem Neonatal
/
Tirosinemias
Tipo de estudo:
Diagnostic_studies
/
Screening_studies
Limite:
Humans
/
Newborn
País/Região como assunto:
America do norte
Idioma:
En
Revista:
Mol Genet Metab
Assunto da revista:
BIOLOGIA MOLECULAR
/
BIOQUIMICA
/
METABOLISMO
Ano de publicação:
2011
Tipo de documento:
Article
País de afiliação:
Estados Unidos